Abstract
Background/Objectives:
To determine if consumption of yogurt containing a high dose of probiotic (1 Ă 1010 colony-forming unit per 100âml), Bifidobacterium animalis subsp. lactis (B. lactis), decreases absences in children 2â4 years attending daycare/school centers.
Subjects/Methods:
We conducted a double-blinded, randomized, placebo-controlled, allocation concealment clinical trial in the Washington, DC area. Our active intervention was a strawberry yogurt-based drink supplemented with B. lactis BB-12. The placebo was indistinguishable from the active drink, differing only in absence of the probiotic BB-12.
Results:
A total of 172 children between the ages of 2 and 4 from the Washington, DC area were enrolled. The primary outcome, missed days of school because of illness per 100 days, was similar in both the active (2.54 days absent/100 school days) and control groups (2.42 days absent/100 school days) (P=0.873).
Conclusions:
The probiotic-containing yogurt-based beverage studied did not decrease absences because of illnesses in daycare/school for healthy children ages 2â4 years.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Abi-Hanna A, Moore N, Yolken R, Saavedra J (1998). Long term consumption of infant formulas with live probiotic bacteria: safety and tolerance. J Pediatr Gastroenterol Nutr 27, 484.
Alm L, Ryd-Kjellen E, Setterberg G, Blomquist L (1993). Effect of a new fermented milk product âCULTURAâ on constipation in geriatric patients. 1st Lactic Acid Bacteria Computer Conference Proceedings. Horizon Scientific Press: Norfolk, England.
Amrouche T, Boutin Y, Fliss I (2006a). Effects of bifidobacterial cytoplasm peptide and protein fractions on mouse lymphocyte proliferation and cytokine production. Food Agr Immunol 17, 29â42.
Amrouche T, Boutin Y, Prioult G, Fliss I (2006b). Effects of bifidobacterial cytoplasm, cell wall and exopolysaccharide on mouse lymphocyte proliferation and cytokine production. Int Dairy J 16, 70â80.
Bartosch S, Woodmansey EJ, Paterson JC, McMurdo ME, Macfarlane GT (2005). Microbiological effects of consuming a synbiotic containing Bifidobacterium bifidum, Bifidobacterium lactis, and oligofructose in elderly persons, determined by real-time polymerase chain reaction and counting of viable bacteria. Clin Infect Dis 40, 28â37.
Black FT, Anderson PL, Orskov J, Orskov F, Gaarslev K, Laulund S et al. (1989). Prophylactic efficacy of lactobacilli on traveler's diarrhea. Travel Med 8, 333â335.
Chouraqui JP, Van Egroo LD, Fichot MC (2004). Acidified milk formula supplemented with Bifidobacterium lactis: impact on infant diarrhea in residential care settings. J Pediatr Gastroenterol Nutr 38, 288â292.
Engelbrektson AL, Korzenik JR, Sanders ME, Clement BG, Leyer G, Klaenhammer TR (2006). Analysis of treatment effects on the microbial ecology of the human intestine. FEMS Microbiol Ecol 57, 239â250.
Food and Agriculture Organization of the United Nations and World Health Organization CĂłrdoba (2001). Health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria. Report of a Joint FAO/WHO Expert Consultation on Evaluation of Health and Nutritional Properties of Probiotics in Food Including Powder Milk with Live Lactic Acid Bacteria. Argentina.
Fukushima Y, Kawata Y, Hara H (1997). Effect of a probiotic formula containing bifidobacteria (Nan BF) on fecal flora and fecal metaboiltes in healthy children. Bioscience Microflora 16, 65â72.
Fukushima Y, Kawata Y, Hara H, Terada A, Misuoka T (1998). Effect of a probiotic formula on intestinal immunoglobulin A production in healthy children. Int J Food Microbiol 42, 39â44.
Hatakka K, Savilahti E, Ponka A, Meurman JH, Poussa T, Nase L et al. (2001). Effect of long term consumption of probiotic milk on infections in children attending day care centres: double blind, randomised trial. BMJ 322, 1327.
Kalliomaki M, Salminen S, Arvilommi H, Kero P, Koskinen P, Isolauri E (2001). Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet 372, 1076â1079.
Kankaanpaa P, Sutas Y, Salmien S, Isolauri E (1998). Results on clinical demonstration of probiotics on children. Presented at Functional Food Research in Europe, Third Workshop. PROBDEMO: Finland.
Kekkonen RA, Lummela N, Karjalainen H, Latvala S, Tynkkynen S, Jarvenpaa S et al. (2008). Probiotic intervention has strain-specific anti-inflammatory effects in healthy adults. World J Gastroenterol 14, 2029â2036.
Lin HC, Su BH, Chen AC, Lin TW, Tsai CH, Yeh TF et al. (2005). Oral probiotics reduce the incidence and severity of necrotizing enterocolitis in very low birth weight infants. Pediatrics 115, 1â4.
Lin JS, Chiu YH, Lin NT, Chu CH, Huang KC, Liao KW et al. (2009). Different effects of probiotic species/strains on infections in preschool children: a double-blind, randomized, controlled study. Vaccine 27, 1073â1079.
Link-Amster H, Rochat F, Saudan KY, Mignot O, Aeschlimann JM (1994). Modulation of a specific humoral immune response and changes in intestinal flora mediated through fermented milk intake. FEMS Immunol Med Microbiol 10, 55â63.
Malinen E, Matto J, Salmitie M, Alander M, Saarela M, Palva A (2002). PCR-ELISA II: analysis of Bifidobacterium populations in human faecal samples from a consumption trial with Bifidobacterium lactis Bb-12 and a galacto-oligosaccharide preparation. Syst Appl Microbiol 25, 249â258.
marketsandmarkets.com(2009): http://www.marketsandmarkets.com/Market-Reports/probiotic-market-advanced-technologies-and-global-market-69.html. Probiotic MarketâAdvanced Technologies and Global Market (2009â2014).
Mastrandrea F, Coradduzza G, Serio G, Minardi A, Manelli M, Ardito S et al. (2004). Probiotics reduce the CD34+ hemopoietic precursor cell increased traffic in allergic subjects. Allerg Immunol 36, 118â122.
Matsumoto M, Ohishi H, Benno Y (2001). Impact of LKM512 yoghurt on improvement of intestinal environment of the elderly. FEMS Immunol Med Microbiol 31, 181â186.
Merenstein DJ, Foster J, DâAmico F (2009). A randomized clinical trial measuring the influence of kefir on antibiotic-associated diarrhea: the measuring the influence of Kefir (MILK) Study. Arch Pediatr Adolesc Med 163, 750â754.
Obradovic D, Curic M, Ivanovic M, Trbojevic B, Djordjevic M (1996). Probiotic function of the fermented milk Jogurt Plus. FEMS Conference (Fifth Symposium on Lactic Acid Bacteria). Holland.
Ouwehand AC, Kurvinen T, Rissanen P (2004). Use of a probiotic Bifidobacterium in a dry food matrix, an in vivo study. Int J Food Microbiol 95, 103â106.
Pedone CA, Bernabeu AO, Postaire ER, Bouley CF, Reinert P (1999). The effect of supplementation with milk fermented by Lactobacillus casei (strain DN-114 001) on acute diarrhoea in children attending day care centres. Int J Clin Pract 53, 179â184.
Phuapradit P, Varavithya W, Vathanophas K, Sangchai R, Podhipak A, Suthutvoravut U et al. (1999). Reduction of rotavirus infection in children receiving bifidobacteria-supplemented formula. J Med Assoc Thai 82 (Suppl 1), 43â48.
Rosenfeldt V, Michaelsen KF, Jakobsen M, Larsen CN, Moller PL, Pedersen P et al. (2002). Effect of probiotic Lactobacillus strains in young children hospitalized with acute diarrhea. Pediatr Infect Dis J 21, 411â416.
Saavedra JM, Abi-Hanna A, Moore N, Yolken RH (2004). Long-term consumption of infant formulas containing live probiotic bacteria: tolerance and safety. Am J Clin Nutr 79, 261â267.
Saavedra JM, Bauman NA, Oung I, Perman JA, Yolken RH (1994). Feeding of Bifidobacterium bifidum and Streptococcus thermophilus to infants in hospital for prevention of diarrhoea and shedding of rotavirus. Lancet 344, 1046â1049.
Schiffrin EJ, Rochat F, Link-Amster H, Aeschlimann JM, Donnet-Hughes A (1995). Immunomodulation of human blood cells following the ingestion of lactic acid bacteria. J Dairy Sci 78, 491â497.
StataCorp (2005). Stata Statistical Software: Release 9. StataCorp LP: College Station, TX, USA.
Taipale T, Pienihäkkinen K, Isolauri E, Larsen C, Brockmann E, Alanen P et al. (2011). Bifidobacterium animalis subsp. lactis BB-12 in reducing the risk of infections in infancy. Br J Nutr 105, 409â416.
Tuohy KM, Rouzaud GCM, Bruck WM, Gibson GR (2005). Modulation of the human gut microflora towards improved health using prebioticsâassessment of efficacy. Curr Pharm Des 11, 75â90.
Vanderhoof JA, Whitney DB, Antonson DL, Hanner TL, Lupo JV, Young RJ (1999). Lactobacillus GG in the prevention of antibiotic-associated diarrhea in children. J Pediatr 135, 564â568.
Ventura M, Reniero R, Zink R (2001). Specific identification and targeted characterization of Bifidobacterium lactis from different environmental isolates by a combined multiplex-PCR approach. Appl Environ Microbiol 67, 2760â2765.
Weizman Z, Asli G, Alsheikh A (2005). Effect of a probiotic infant formula on infections in child care centers: comparison of two probiotic agents. Pediatrics 115, 5â9.
Acknowledgements
We would like to thank Spencer Whitlock, research assistant, and CAPRICORN research coordinator Tina Tan, for their invaluable help. We would also like to thank the Data Safety Monitoring Board, Tamar Ringel-Kulka, MD (Chair), Alan Simon, MD and Felice Roggen, JD. We are also indebted to Etta Saltos, National Program Leader of Human Nutrition at the National Institute of Food and Agriculture, USDA and to the USDA for their help and financial support. This project was supported by National Research Initiative Grant 2008-35200-04475 from the USDA National Institute of Food and Agriculture.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
Dr Mary Ellen Sanders consults for numerous probiotic manufacturers. From 2006â2008, Amy GuimarĂŁes Young worked for a health sciences consulting company that conducted safety evaluations for probiotic manufacturers. The remaining authors declare no conflict of interest.
Additional information
Contributors: Study concept and design: DM, RFR, SP, MES; acquisition of data: DM, AGY, Whitlock, JG; analysis and interpretation of data: DM, JG, RFR, SP, MES; initial drafting of the paper: DM, JG; critical revision of the paper for important intellectual content: RFR, SP, MES; statistical analysis: SP, DM; obtained funding: DM.
Rights and permissions
About this article
Cite this article
Merenstein, D., Gonzalez, J., Young, A. et al. Study to investigate the potential of probiotics in children attending school. Eur J Clin Nutr 65, 447â453 (2011). https://doi.org/10.1038/ejcn.2010.290
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ejcn.2010.290
Keywords
This article is cited by
-
Probiotics for respiratory tract infections in children attending day care centersâa systematic review
European Journal of Pediatrics (2018)
-
Effects of Bifidobacterium animalis subsp. lactis BB-12ÂŽ on the lipid/lipoprotein profile and short chain fatty acids in healthy young adults: a randomized controlled trial
Nutrition Journal (2017)
-
Consumption of Bifidobacterium animalis subsp. lactis BB-12 in yogurt reduced expression of TLR-2 on peripheral blood-derived monocytes and pro-inflammatory cytokine secretion in young adults
European Journal of Nutrition (2017)
-
SchĂźtzen Immunstimulanzien vor Infektionen?
Pädiatrie (2012)